FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040607903> ?p ?o ?g. }

• W2040607903 endingPage "167" @default.
• W2040607903 startingPage "158" @default.
• W2040607903 abstract "Angiotensin II (A II), the main effector of the renin angiotensin system (RAS), plays a central role in the hemodynamic and nonhemodynamic mechanisms of chronic renal disease and is currently the main target of interventions aimed to prevent the onset and progression of chronic nephropathies to end-stage renal disease (ESRD). In addition, to ameliorate glomerular hyperfiltration and size selectivity, reduce protein traffic and prevent glomerular and tubulointerstitial toxicity of ultrafiltered proteins, RAS inhibitors also limit the direct nephrotoxic effects of A II. Thus, both angiotension-converting enzyme (ACE) inhibitors (ACEi) and A II antagonists (ATA) exert a specific nephroprotective effect in both experimental and human chronic renal disease. This effect is time-dependent and is observed across degrees of renal insufficiency. Forced ACEi or ATA uptitration above doses recommended to control arterial hypertension and combined treatment with both agents allow optimization of A II inhibition and maximization of renoprotection. Multifactorial interventions combining RAS inhibition to treatments targeted also to non-RAS mechanisms could even achieve regression of glomerulosclerosis and chronic tubulointerstitial injury. Studies are needed to assess whether renal damage can be reverted to such a point that renal function could be fully prevented from worsening, and possibly improvement. The economic impact of even a partial improvement would be enormous. Moreover, chronic renal insufficiency is an independent risk factor for cardiovascular disease, and effective nephroprotection could also decrease the excess cardiovascular morbidity and mortality associated with chronic nephropathies. In patients with renal insufficiency, ACEi are even more cardioprotective than in those without and are well tolerated. Thus, RAS inhibitor therapy should be offered to all renal patients without specific contraindications, including those closer to renal replacement therapy." @default.
• W2040607903 created "2016-06-24" @default.
• W2040607903 creator A5059276594 @default.
• W2040607903 date "2004-03-01" @default.
• W2040607903 modified "2023-09-26" @default.
• W2040607903 title "Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies" @default.
• W2040607903 cites W1577181385 @default.
• W2040607903 cites W180946569 @default.
• W2040607903 cites W1931208941 @default.
• W2040607903 cites W1963849118 @default.
• W2040607903 cites W1968002068 @default.
• W2040607903 cites W1972868666 @default.
• W2040607903 cites W1973654475 @default.
• W2040607903 cites W1977533194 @default.
• W2040607903 cites W1983805610 @default.
• W2040607903 cites W1994544110 @default.
• W2040607903 cites W1994887713 @default.
• W2040607903 cites W1995831330 @default.
• W2040607903 cites W2000512590 @default.
• W2040607903 cites W2002237956 @default.
• W2040607903 cites W2008617568 @default.
• W2040607903 cites W2011333765 @default.
• W2040607903 cites W2016046345 @default.
• W2040607903 cites W2016715625 @default.
• W2040607903 cites W2018680608 @default.
• W2040607903 cites W2019639026 @default.
• W2040607903 cites W2019906442 @default.
• W2040607903 cites W2022168978 @default.
• W2040607903 cites W2022724650 @default.
• W2040607903 cites W2024231135 @default.
• W2040607903 cites W2026067095 @default.
• W2040607903 cites W2026639881 @default.
• W2040607903 cites W2028626467 @default.
• W2040607903 cites W2047056322 @default.
• W2040607903 cites W2047372165 @default.
• W2040607903 cites W2051046569 @default.
• W2040607903 cites W2055720683 @default.
• W2040607903 cites W2056038215 @default.
• W2040607903 cites W2058669050 @default.
• W2040607903 cites W2068509905 @default.
• W2040607903 cites W2074757264 @default.
• W2040607903 cites W2075474963 @default.
• W2040607903 cites W2081039184 @default.
• W2040607903 cites W2084144472 @default.
• W2040607903 cites W2091715978 @default.
• W2040607903 cites W2092389955 @default.
• W2040607903 cites W2094778189 @default.
• W2040607903 cites W2100124500 @default.
• W2040607903 cites W2102751959 @default.
• W2040607903 cites W2119682331 @default.
• W2040607903 cites W2120235169 @default.
• W2040607903 cites W2125964049 @default.
• W2040607903 cites W2128661749 @default.
• W2040607903 cites W2132123447 @default.
• W2040607903 cites W2136898798 @default.
• W2040607903 cites W2138670606 @default.
• W2040607903 cites W2143144750 @default.
• W2040607903 cites W2143435733 @default.
• W2040607903 cites W2147696440 @default.
• W2040607903 cites W2147804563 @default.
• W2040607903 cites W2155401923 @default.
• W2040607903 cites W2156632978 @default.
• W2040607903 cites W2157734027 @default.
• W2040607903 cites W2165325650 @default.
• W2040607903 cites W2168250371 @default.
• W2040607903 cites W2169896560 @default.
• W2040607903 cites W2170448618 @default.
• W2040607903 cites W2312400976 @default.
• W2040607903 cites W2318993770 @default.
• W2040607903 cites W2331176038 @default.
• W2040607903 cites W2416034273 @default.
• W2040607903 cites W3156148333 @default.
• W2040607903 cites W4238849664 @default.
• W2040607903 cites W4245133279 @default.
• W2040607903 cites W4300803867 @default.
• W2040607903 doi "https://doi.org/10.1016/j.semnephrol.2003.11.002" @default.
• W2040607903 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15017528" @default.
• W2040607903 hasPublicationYear "2004" @default.
• W2040607903 type Work @default.
• W2040607903 sameAs 2040607903 @default.
• W2040607903 citedByCount "36" @default.
• W2040607903 countsByYear W20406079032012 @default.
• W2040607903 countsByYear W20406079032013 @default.
• W2040607903 countsByYear W20406079032016 @default.
• W2040607903 countsByYear W20406079032018 @default.
• W2040607903 crossrefType "journal-article" @default.
• W2040607903 hasAuthorship W2040607903A5059276594 @default.
• W2040607903 hasConcept C126322002 @default.
• W2040607903 hasConcept C126894567 @default.
• W2040607903 hasConcept C134018914 @default.
• W2040607903 hasConcept C159641895 @default.
• W2040607903 hasConcept C27016395 @default.
• W2040607903 hasConcept C2777390665 @default.
• W2040607903 hasConcept C2778653478 @default.
• W2040607903 hasConcept C2779561371 @default.
• W2040607903 hasConcept C2780091579 @default.
• W2040607903 hasConcept C2908929049 @default.
• W2040607903 hasConcept C71924100 @default.

• next